DIPROPHOS susp inj 5 amp 1 ml

7680395280299 CH-39528 H02AB01 07.07.25

Active substances:

DIPROPHOS susp inj 5 amp 1 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
3952802
CPT
-
Packaging group
5 x 1 ml
Unit
Ampulle(n)
Composition
betamethasonum 5 mg ut betamethasoni dipropionas, betamethasonum 2 mg ut betamethasoni natrii phosphas, dinatrii phosphas dihydricus, natrii chloridum, dinatrii edetas, polysorbatum 80, alcohol benzylicus 9 mg, E 218 1.3 mg, macrogolum 3350, propylis parahydroxybenzoas 0.2 mg, carmellosum natricum, acidum hydrochloridum, q.s. ad suspensionem pro 1 ml corresp. aqua ad iniectabile natrium 3.4 mg.

Articles (1)

Diprophos, Injektionssuspension
Injektionssuspension
5 x 1 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/03/2026
Professional SmPC
Français
18/03/2026

Detailed composition

Substance Quantity Type Category
betamethasonum
5.0 MG Substance Wirkstoff (Principe actif)
betamethasoni dipropionas
- Substance WIZUS
betamethasonum
2.0 MG Substance Wirkstoff (Principe actif)
betamethasoni natrii phosphas
- Substance WIZUS
dinatrii phosphas dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
alcohol benzylicus
9.0 MG Substance HBESI
E 218
1.3 MG Substance HBESI
macrogolum 3350
- Substance HNIDK
propylis parahydroxybenzoas
0.2 MG Substance HBESI
carmellosum natricum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.4 MG Substance HBESI

Reimbursement information

Public price
CHF 40.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2020

Authorization holder

Organon GmbH

6006 Luzern

Authorization information

Swissmedic authorization number
39528
Drug name
Diprophos, Injektionssuspension
Galenic form
SUPA
ATC Code
H02AB01
Authorization status
Z
Dispensation category
B
First authorization
30/03/1976
Authorization expiration date
31/12/9999
IT number
07.07.25
Domain
Human medicine
Field of application
Intramuskuläre und lokale Glukokortikosteroid-Therapie

Packaging details

Description (FR)
DIPROPHOS susp inj 5 amp 1 ml
Description (DE)
DIPROPHOS Inj Susp 5 Amp 1 ml
Market launch
30/03/1976
Narcotic (BTM)
No

Other packaging sizes

DIPROPHOS susp inj amp 1 ml
1 x 1 ml AMP
View
DIPROPHOS susp inj ser usage unique 1 ml
1 x 1 ml FESP
View
Buy us a coffee Explore the data